Evolent Health, Inc. EVH
Set alert
4.32 USD -0.13 -3.03%
As of Nov 3, 2:49 PM ET
4.31 Day range 4.44
2.10 52-week range 6.89
- YTD
- +7.88%
- 1 year
- -35.79%
- Open
- 4.45
- Prev close
- 4.45
- Mkt cap
- 487.85M
- Vol
- 513.70K
- Avg vol
- 2.46M
- EPS
- -4.49
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.31
- High
- 4.44
- Forward P/E
- 6.01
- Beta
- 0.73
- Short ratio
- 6.55
- Inst. own
- 108.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 6, 2025
- 50-d avg
- 9.86
- 200-d avg
- 9.96
- 1y target
- 15.46
1M chart
Signals (8)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 28, 2026 | 6 days ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| RSI: Overbought | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 7, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 15.46 +258.3% upside
Now 4.32
- Target (low)
- 9.00
- Target (mean)
- 15.46
- Target (high)
- 20.00
Ratings (0m) 14 13 buy · 1 hold · 0 sell
- Strong buy4
- Buy9
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 14
- 3 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.10522 | 0.05456 – 0.20 | 0.04 | +163.1% | 473.74M | -23.8% | 11 |
| Next quarter | 0.12388 | 0.05 – 0.22 | -0.02 | +719.4% | 482.03M | -25.4% | 11 |
| Current year | 0.2243 | 0.03059 – 0.38 | 0.41 | -45.3% | 1.88B | -26.3% | 11 |
| Next year | 0.63439 | 0.41 – 1.12 | 0.2243 | +182.8% | 2.42B | +28.4% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 9, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 9, 2025 | BTIG | Reiterated | Buy | Buy |
| Aug 28, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 17, 2025 | Truist Securities | Maintained | Buy | Buy |
| Jun 20, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| May 13, 2025 | Needham | Reiterated | Buy | Buy |
| May 9, 2025 | UBS | Maintained | Buy | Buy |
| Apr 28, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 10, 2025 | Truist Securities | Maintained | Buy | Buy |
| Mar 10, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 24, 2025 | Citizens Capital Markets | Maintained | Market Outperform | Market Outperform |
| Feb 21, 2025 | Piper Sandler | Reiterated | Overweight | Overweight |
| Feb 21, 2025 | Needham | Reiterated | Buy | Buy |
| Feb 14, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Feb 12, 2025 | Needham | Reiterated | Buy | Buy |
| Jan 28, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Jan 24, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Jan 24, 2025 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jan 23, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Jan 22, 2025 | Truist Securities | Maintained | Buy | Buy |
| Jan 21, 2025 | Stephens & Co. | Maintained | Equal-Weight | Equal-Weight |
| Jan 16, 2025 | UBS | Maintained | Buy | Buy |
| Jan 15, 2025 | Needham | Reiterated | Buy | Buy |
| Jan 14, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Jan 13, 2025 | Truist Securities | Maintained | Buy | Buy |
| Jan 10, 2025 | Citigroup | Maintained | Buy | Buy |
| Jan 10, 2025 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jan 10, 2025 | Needham | Initiated | — | Buy |
| Nov 22, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 18, 2024 | Oppenheimer | Maintained | Outperform | Outperform |